title: Reply to the article "Metronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regression, and is devoid of toxicity" by V. R. Rozados et al. (Ann Oncol 2004; 15: 1543-1550): ... and in humans?
authors.forename: T
authors.initials: T
authors.lastname: De Pas
authors.forename: M
authors.initials: M
authors.lastname: Colleoni
authors.forename: L
authors.initials: L
authors.lastname: Orlando
authors.forename: G
authors.initials: G
authors.lastname: Masci
authors.forename: A
authors.initials: A
authors.lastname: Rocca
authors.forename: C
authors.initials: C
authors.lastname: Catania
authors.forename: G
authors.initials: G
authors.lastname: Curigliano
authors.forename: S
authors.initials: S
authors.lastname: Manzoni
authors.forename: A
authors.initials: A
authors.lastname: Goldhirsch
authors.forename: F
authors.initials: F
authors.lastname: de Braud
mesh_terms: D000328:Adult; D000368:Aged; D000818:Animals; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D011446:Prospective Studies; D051381:Rats; D012074:Remission Induction; D012509:Sarcoma / Q000188:drug therapy* / Q000473:pathology
chemical_list: D003520:Cyclophosphamide